Last updated: 17 May 2019 at 5:49pm EST

Kathy Yi Net Worth




The estimated Net Worth of Kathy Yi is at least $25.6 Thousand dollars as of 15 May 2019. Kathy Yi owns over 5,000 units of Sangamo Therapeutics Inc stock worth over $25,630 and over the last 8 years Kathy sold SGMO stock worth over $0.

Kathy Yi SGMO stock SEC Form 4 insiders trading

Kathy has made over 15 trades of the Sangamo Therapeutics Inc stock since 2018, according to the Form 4 filled with the SEC. Most recently Kathy exercised 5,000 units of SGMO stock worth $22,750 on 15 May 2019.

The largest trade Kathy's ever made was exercising 5,000 units of Sangamo Therapeutics Inc stock on 15 May 2019 worth over $22,750. On average, Kathy trades about 3,947 units every 22 days since 2017. As of 15 May 2019 Kathy still owns at least 30,512 units of Sangamo Therapeutics Inc stock.

You can see the complete history of Kathy Yi stock trades at the bottom of the page.



What's Kathy Yi's mailing address?

Kathy's mailing address filed with the SEC is 501 Canal Blvd, Richmond, CA 94804, USA.

Insiders trading at Sangamo Therapeutics Inc

Over the last 24 years, insiders at Sangamo Therapeutics Inc have traded over $87,969,621 worth of Sangamo Therapeutics Inc stock and bought 3,434,008 units worth $48,483,268 . The most active insiders traders include Capital Management, L.P.Ra ..., Le Roy C Kopp, and Inc.Biogen Ma Inc. Biogen. On average, Sangamo Therapeutics Inc executives and independent directors trade stock every 21 days with the average trade being worth of $40,671. The most recent stock trade was executed by Inc.Biogen Ma Inc. Biogen on 26 September 2023, trading 6,000,000 units of SGMO stock currently worth $3,000,000.



What does Sangamo Therapeutics Inc do?

for sangamo therapeutics, science is a means to develop new medicines with the potential to transform the lives of patients living with serious genetic diseases. our scientists are leaders in the discovery, research and development of technologies enabling gene-based therapeutic development. currently we are conducting clinical trials, including the first ever in vivo human genome editing studies. to learn more about sangamo, visit the our website at www.sangamo.com.



Complete history of Kathy Yi stock trades at Sangamo Therapeutics Inc

Insider
Trans.
Transaction
 Total value
Kathy Yi
EVP and Chief Financial Officer
 Option $22,750
15 May 2019
Kathy Yi
EVP and Chief Financial Officer
 Option $22,750
15 Apr 2019
Kathy Yi
EVP and Chief Financial Officer
 Option $22,750
15 Mar 2019
Kathy Yi
EVP and Chief Financial Officer
 Option $22,750
1 Mar 2019
Kathy Yi
EVP and Chief Financial Officer
 Option $22,750
15 Jan 2019
Kathy Yi
EVP and Chief Financial Officer
 Option $22,750
17 Dec 2018
Kathy Yi
EVP and Chief Financial Officer
 Option $22,750
15 Nov 2018
Kathy Yi
EVP and Chief Financial Officer
 Option $22,750
15 Oct 2018
Kathy Yi
EVP and Chief Financial Officer
 Option $22,750
17 Sep 2018
Kathy Yi
EVP and Chief Financial Officer
 Option $22,750
16 Aug 2018
Kathy Yi
EVP and Chief Financial Officer
 Option $22,750
16 Jul 2018
Kathy Yi
EVP and Chief Financial Officer
 Option $22,750
15 Jun 2018
Kathy Yi
EVP and Chief Financial Officer
 Option $22,750
15 May 2018
Kathy Yi
EVP and Chief Financial Officer
 Option $22,750
16 Apr 2018
Kathy Yi
EVP and Chief Financial Officer
 Option $22,750
15 Mar 2018


Sangamo Therapeutics Inc executives and stock owners

Sangamo Therapeutics Inc executives and other stock owners filed with the SEC include: